Abstract:Objective To investigate the influence of recombinant human granulocyte colony stimulating factor (rhG-CSF) on CD34+ hematopoietic stem cells and regulatory T cells in healthy donors.Method Seventy-five healthy donors were retrospectively analyzed in this study,including 65 related donors and 10 unrelated donors.All the donors were mobilized with rhG-CSF (5-7.5 μg·kg-1 ·d-1).Blood routine and the percentage of CD34+ stem cells in peripheral blood were monitored during mobilization.Bone marrow stem cells on day 4,and peripheral blood stem cells on day 5 and/or 6 were collected for related donors.Peripheral blood stem cells were collected on day 5 for unrelated donors.Flow cytometry was used to detect CD34+ cells,total T lymphocytes (CD3+),and regulatory T cells (CD4+ CD25 + CD127-).Result After rhG-CSF mobilization,the percentage of CD34+ stem cells was 0.13％ ± 0.07％ in bone marrow harvests,and 0.36％ ± 0.21％ in peripheral blood products (u =7.167,P＜0.001).When converted to absolute number,the CD34+ cells were (53.25 ± 33.59)/μl in bone marrow harvests,which was significantly lower than that (874.33 ± 540.15)/μl in peripheral blood products (u =6.714,P＜0.001).The percentage of regulatory T cells was 0.81％ (0.40％,6.09％) in bone marrow harvests,and 1.03％ (0.41％,5.70％) in peripheral blood products,without significant difference (u =0.131,P =0.894).The absolute number of regulatory T cells was obviously lower in bone marrow harvests (129.12 ± 100.90)/μl than in peripheral blood products (3357.34 ± 2831.72)/μl (u =6.389,P＜0.001).Although the absolute number of T cells was higher in peripheral blood products (51 221.92 ± 17 128.01)/μl than in bone marrow harvests (2 101.82 ± 1 288.93)/μl (u =6.784,P＜0.001),no significant difference was detected for regulatory T cells/total T cells ratio (0.069 ± 0.048 versus 0.067 ± 0.048/μl;t =0.211,P =0.833).Conclusion High frequency and absolute number of CD34+ stem cells in peripheral blood harvests may be partially associated with rapid hematopoietic reconstitution after transplantation.Similar regulatory T cells/total T cells ratio may contribute to the similar occurrence of acute graft versus host disease.

STUDY ON THE RELATIONSHIP BETWEEN HEMATOPOIETIC GROWTH FACTOR ACTIVITIES IN THE PLASMA OF BONE MARROW TRANSPLANTATION RECIPIENTS AND HEMATOPOIETIC RECONSTRUCTION

Effect of hepatocyie growth factor on haematopoietic reconstruction after syngeneic bone marrow transplantation in mice

An Unbalanced Monocyte Macrophage Polarization In The Bone Marrow Microenvironment Of Patients With Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.

[Study of Ex Vivo Expansion of Mouse Hematopoietic Stem/progenitor Cells and the Use of Them for Hematopoiesis Reconstitution].

Ex Vivo Expansions and Transplantations of Mouse Bone Marrow-Derived Hematopoietic Stem/progenitor Cells

Experimental Study on Hematopoietic Reconstruction Effects of Peripheral Blood Stem Cells Mobilized by Anti-Cd49d Monoclonal Antibody Plus Rhg-Csf in Mice

Analysis on expansion potentials and pre-clinical safeties of hematopoietic stem cells from human umbilical cord blood.

Effects of Expanded Hematopoietic Stem/progenitor Cells on Mouse Hematopoietic Recovery:Rapid Hematopoietic Recovery, Long-Term Engraftment and Endogenous Recovery

The rule of hematopoiesis reconstruction after peripheral blood stem cell transplantation and analysis of the correlative factors

[Hematopoietic Reconstitution on the Prognosis of Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation].

Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice.

[Effect of Bone Marrow Graft Collection on Composition of Peripheral Blood Stem Cell Grafts from Healthy Donors after Recombinant Human Granulocyte Colony-Stimulating Factor Application in Vivo for Mobilization].

Use of Neuroendocrine Hormones to Promote Reconstitution after Bone Marrow Transplantation

Factors Influencing Engraftment in Hematological Patients after Human Leukocyte Antigen Matched Sibling Allogeneic Blood and Marrow Transplantation

Clinical Study of G-CSF Mobilized Allogeneic Bone Marrow Cells Plus Peripheral Blood Stem Cells Transplantation for Hematological Diseases

Analysis of 66 Cases Received Hematopoietic Stem Cell Transplantation from Unrelated Donors

Single-cell dissection of human hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation

Post-transplantation monitoring and quantitation of microparticles in allogeneic hematopoietic cell transplantation

Influence of Recombinant Human Granulocyte Colony Stimulating Factor (Rhg-Csf) on CD34+ Hematopoietic Stem Cells and Regulatory T Cells in Healthy Donors

Clinieal study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for hematological diseases